Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Food and Drug Administration (FDA) postmarket reviews have identified serious adverse reactions that have resulted in death of newborns associated with the use of ceftriaxone and calcium salt in the body. Ceftriaxone is often used in infants between 4 and 8 weeks of age who have a high fever and are admitted to the hospital.

Read the rest of this entry »